Get the Stockscreener App
0.8901
2.24%
0.0195
Heartbeam Inc stock is traded at $0.8901, with a volume of 364.95K.
It is up +2.24% in the last 24 hours and down -25.20% over the past month.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
See More
Previous Close:
$0.8706
Open:
$0.91
24h Volume:
364.95K
Relative Volume:
0.26
Market Cap:
$47.74M
Revenue:
-
Net Income/Loss:
$-21.02M
P/E Ratio:
-1.4208
EPS:
-0.6265
Net Cash Flow:
$-14.59M
1W Performance:
+0.94%
1M Performance:
-25.20%
6M Performance:
-46.05%
1Y Performance:
-50.82%
1-Day Range:
$0.8828
$0.9199
1-Week Range:
$0.83
$0.9253
52-Week Range:
$0.54
$4.00
Heartbeam Inc Stock (BEAT) Company Profile
Name
Heartbeam Inc
Sector
Industry
Phone
408-899-4443
Address
2118 WALSH AVE., SUITE 210, SANTA CLARA
Compare BEAT vs VEEV, BTSG, TEM, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
0.8901 | 47.74M | 0 | -21.02M | -14.59M | -0.6265 |
VEEV
Veeva Systems Inc
|
166.34 | 27.15B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
54.83 | 10.63B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
49.86 | 8.95B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
84.84 | 7.17B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
25.98 | 4.80B | 637.78M | 239.40M | 307.21M | 1.1909 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-20-26 | Downgrade | D. Boral Capital | Buy → Hold |
| Mar-31-26 | Initiated | B. Riley Securities | Buy |
| Mar-27-26 | Initiated | D. Boral Capital | Buy |
| Mar-16-26 | Downgrade | The Benchmark Company | Buy → Speculative Buy |
| Dec-11-25 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-08-25 | Initiated | H.C. Wainwright | Buy |
| Oct-31-25 | Initiated | Roth Capital | Buy |
| Sep-11-20 | Initiated | Needham | Buy |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Aug-02-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-26-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-18 | Reiterated | Lake Street | Buy |
| Apr-26-18 | Reiterated | The Benchmark Company | Buy |
| Feb-23-18 | Reiterated | Dougherty & Company | Buy |
| Nov-08-17 | Reiterated | Dougherty & Company | Buy |
| Oct-26-17 | Initiated | Raymond James | Outperform |
| Oct-24-17 | Initiated | SunTrust | Buy |
| Aug-09-17 | Reiterated | Dougherty & Company | Buy |
| Jul-19-17 | Reiterated | The Benchmark Company | Buy |
| Apr-11-17 | Reiterated | Dougherty & Company | Buy |
| Dec-02-16 | Initiated | Dougherty & Company | Buy |
| Sep-13-16 | Initiated | Sidoti | Buy |
| Aug-03-16 | Reiterated | The Benchmark Company | Buy |
| Jul-28-15 | Reiterated | Dougherty & Company | Buy |
| Oct-24-13 | Initiated | The Benchmark Company | Buy |
| Aug-21-13 | Initiated | Dougherty & Company | Buy |
View All
Heartbeam Inc Stock (BEAT) Latest News
HeartBeam (NASDAQ: BEAT) Expands Concierge Cardiology Footprint With Atelier Health Agreement - USA Today
HeartBeam (BEAT) Expands Concierge Cardiology Footprint With Atelier Health Agreement - NewMediaWire
HeartBeam Expands Market Reach to Four Major U.S. Markets Through Concierge Practice Integration - geneonline.com
HeartBeam expands commercial presence across four key U.S. markets with addition of Premier Concierge Practice - marketscreener.com
HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice - Yahoo Finance UK
HeartBeam (BEAT) Tackles Heart Disease With Next-Generation ECG Solutions - Yahoo Finance
HeartBeam (NASDAQ: BEAT) Tackles Heart Disease with Next-Generation ECG Solutions - TradingView
HeartBeam (NASDAQ: BEAT) to Host Q1 2026 Earnings Call and Provide Strategic Updates - USA Today
HeartBeam (NASDAQ: BEAT) Collaborates to Advance Next-Gen ECG Solutions - USA Today
BEAT Forecast, Price Target & Analyst Ratings | HEARTBEAM INC (NASDAQ:BEAT) - ChartMill
HeartBeam (BEAT) to Host Q1 2026 Earnings Call and Provide Strategic Updates - NewMediaWire
HeartBeam call will cover arrhythmia launch, patch and AI updates - Stock Titan
HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time - Business Wire
HeartBeam slips 12%, prices $10M stock offering - MSN
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer - The National Law Review
Director Richard Ferrari buys 57,500 HeartBeam (BEAT) shares in public offering - Stock Titan
HeartBeam (BEAT): 10 Best NASDAQ Growth Stocks to Buy and Hold Forever - Insider Monkey
HeartBeam (BEAT) Collaborates to Advance Next-Gen ECG Solutions - Yahoo Finance
BEAT Heartbeam shares rise 4.35 percent despite narrowly missing Q4 2025 adjusted EPS estimates.Stock Community Signals - Xã Thanh Hà
HeartBeam announces stock offering; shares drop 18% after-hours - MSN
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 earnings call transcript - MSN
BEAT Stock Price, Quote & Chart | HEARTBEAM INC (NASDAQ:BEAT) - ChartMill
Heartbeam (BEATW) Stock: Investment Opportunities (-1.04%) 2026-04-20Stock Accumulation - Xã Châu Thành
D. Boral Capital cuts Heartbeam stock rating on capital raise terms By Investing.com - Investing.com South Africa
D. Boral Capital cuts Heartbeam stock rating on capital raise terms - Investing.com
BEAT SEC FilingsHeartbeam Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Heartbeam (BEAT) Stock Risk Factors (Skyrockets) 2026-04-18Certified Trade Ideas - Cổng thông tin điện tử tỉnh Tây Ninh
HeartBeam closes USD 10M public offering - Medical Buyer
HeartBeam closes $10M public offering for product rollout By Investing.com - Investing.com Australia
HeartBeam (BEAT) Closes $10M Public Offering to Advance Cardiac Technology Commercialization - NewMediaWire
HeartBeam (NASDAQ: BEAT) Closes $10M Public Offering to Advance Cardiac Technology Commercialization - TipRanks
HeartBeam Announces Proposed Public Offering to Advance FDA-Cleared 12-Lead ECG System and Cardiac AI Technology 1 - Minichart
Heartbeam director Ortigas-Wedekind buys $20,000 in stock By Investing.com - Investing.com Australia
Ferrari Richard buys HeartBeam (BEAT) shares worth $50000 By Investing.com - Investing.com Australia
Heartbeam (BEAT) director Strome buys $600k in shares By Investing.com - Investing.com South Africa
Eno Robert Paul, president of HeartBeam, buys $10k in shares By Investing.com - Investing.com Australia
Eno Robert Paul, president of HeartBeam, buys $10k in shares - Investing.com
Heartbeam (BEAT) director Strome buys $600k in shares - Investing.com UK
Ferrari Richard buys HeartBeam (BEAT) shares worth $50000 - Investing.com
Heartbeam director Ortigas-Wedekind buys $20,000 in stock - Investing.com
Heartbeam CFO Cruickshank buys $25,000 in shares By Investing.com - Investing.com South Africa
Heartbeam director Vajdic buys $25,000 in company stock - Investing.com
Heartbeam CFO Cruickshank buys $25,000 in shares - Investing.com
Heartbeam Inc Stock (BEAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Heartbeam Inc Stock (BEAT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Elfrink Willem | Director |
Apr 16 '26 |
Buy |
0.80 |
187,500 |
150,000 |
538,667 |
| JAFF MICHAEL R | Director |
Apr 16 '26 |
Buy |
0.80 |
31,250 |
25,000 |
31,250 |
| Vajdic Branislav | Director |
Apr 16 '26 |
Buy |
0.80 |
31,250 |
25,000 |
909,914 |
| Ferrari Richard | Director |
Apr 16 '26 |
Buy |
0.80 |
62,500 |
50,000 |
291,636 |
| ENO Robert Paul | President |
Apr 16 '26 |
Buy |
0.80 |
12,500 |
10,000 |
36,742 |
| Ortigas-Wedekind Marga | Director |
Apr 16 '26 |
Buy |
0.80 |
25,000 |
20,000 |
137,293 |
| STROME MARK E | Director |
Apr 16 '26 |
Buy |
0.80 |
750,000 |
600,000 |
3,650,000 |
| STROME MARK E | 10% Owner |
Dec 17 '25 |
Sale |
3.58 |
250,000 |
895,000 |
2,900,000 |
| de Urioste George | Director |
Dec 18 '25 |
Sale |
2.83 |
33,185 |
93,914 |
0 |
| de Urioste George | Director |
Dec 17 '25 |
Sale |
3.68 |
23,961 |
88,176 |
33,185 |
3.66%
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):